n(omega)-hydroxyarginine has been researched along with Nomega-hydroxy-nor-l-arginine in 1 studies
Studies (n(omega)-hydroxyarginine) | Trials (n(omega)-hydroxyarginine) | Recent Studies (post-2010) (n(omega)-hydroxyarginine) | Studies (Nomega-hydroxy-nor-l-arginine) | Trials (Nomega-hydroxy-nor-l-arginine) | Recent Studies (post-2010) (Nomega-hydroxy-nor-l-arginine) |
---|---|---|---|---|---|
139 | 0 | 24 | 6 | 0 | 6 |
Protein | Taxonomy | n(omega)-hydroxyarginine (IC50) | Nomega-hydroxy-nor-l-arginine (IC50) |
---|---|---|---|
Arginase-1 | Homo sapiens (human) | 3.68 | |
Arginase-1 | Rattus norvegicus (Norway rat) | 1.4 | |
Arginase-1 | Bos taurus (cattle) | 2.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Blaszczyk, R; Borek, B; Gajda, T; Golebiowski, A | 1 |
1 review(s) available for n(omega)-hydroxyarginine and Nomega-hydroxy-nor-l-arginine
Article | Year |
---|---|
Boronic acid-based arginase inhibitors in cancer immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arginase; Arginine; Boronic Acids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Immunotherapy; Structure-Activity Relationship | 2020 |